Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization (Q28191605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Guadalupe Mengod

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

S Pérez-Torres

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Tolnay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Probst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J M Palacios

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Experimental Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

322-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

6 November 2019

in situ hybridization

1 reference

based on heuristic

inferred from title

cites work

Optimal conditions for hybridization with oligonucleotides: A study with myc-oncogene DNA probes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Neuropathological stageing of Alzheimer-related changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Frequency of stages of Alzheimer-related lesions in different age categories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Evolution of neuronal changes in the course of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Evolution of Alzheimer's disease related cortical lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Characterization of human cDNA and genomic clones for glial fibrillary acidic protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

PDE4 cAMP-specific phosphodiesterases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Tailoring cAMP-signalling responses through isoform multiplicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

CD3- and CD28-dependent induction of PDE7 required for T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Anti-inflammatory drugs and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Phosphodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-alpha(1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Identification of human PDE7B, a cAMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

The molecular pathology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900042-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-4886(03)00042-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895443%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference